Latin American Cooperative Oncology Group
Clinical trials sponsored by Latin American Cooperative Oncology Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study maps cancer treatment journeys across latin america Results expected Sep 2026 (estimated)
- AI may help tailor cancer care for seniors, study puts it to the test Results expected Jan 2027 (estimated)
- Can a nationwide charting of brain tumors reveal who is most affected? Results expected Mar 2027 (estimated)
- Chemo-Free hope for HER2+ breast cancer patients in new trial Results expected Apr 2027 (estimated)
- Can tumor markers guide future ovarian cancer treatments? Results expected Apr 2027 (estimated)
-
New cocktail targets lung cancer brain metastases
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—datopotamab deruxtecan, carboplatin, and pembrolizumab—in 46 people with non-small cell lung cancer that has spread to the brain and who have not had prior treatment for those brain tumors. The goal is to see how well the…
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New study maps cancer treatment journeys across latin america
Knowledge-focused Recruiting nowThis study looks back at medical records of 200 adults in Latin America with a rare and aggressive cancer called neuroendocrine carcinoma. Researchers want to understand how patients are diagnosed, what treatments they receive, and how their disease progresses over time. The goal…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC